Evidence map›Paper›PMID 41653437›Full record

ArticleSTAR protocols2026

Protocol for non-invasive tumor monitoring and diagnosis based on interpretable deep learning.

Zhenbo Yuan, Yuli Yan, Youpeng Yang, Xin Li

Abstract read
In one paragraph

Article in STAR protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhenbo YuanSchool of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.
Yuli YanSchool of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.
Youpeng YangSchool of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen, China. Electronic address: yangyp33@alumni.sysu.edu.cn.
Xin LiSchool of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen, China. Electronic address: lixin253@mail.sysu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor-specific DNA methylation profiling in plasma cell-free DNA (cfDNA) offers a promising approach for non-invasive tumor detection. Here, we present a protocol that uses Oncoder, an interpretable deep-learning-based framework, to monitor treatment response by tracking dynamic changes in tumor-specific DNA methylation signals in patient plasma cfDNA. We describe steps for data preparation, performing differential methylation analysis, training Oncoder, and interpreting the model's outputs. This protocol is versatile and adaptable to various data types and application scenarios. For complete details on the use and execution of this protocol, please refer to Yang et al.

Indexed as

Deep LearningNeoplasmsBiomarkers, TumorDNA MethylationHumansBiomarkers, TumorBioinformaticsCancerSequence analysis

Identifiers

PMID41653437
PMCPMC12907704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.